Pantoprazole and Evenity drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pantoprazole (pantoprazole sodium) and Evenity (romosozumab-aqqg). Common drug interactions include carotid arteriosclerosis among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people have when they take Pantoprazole and Evenity. It is created by eHealthMe based on reports of 42 people who take the same drugs from the FDA, and is updated regularly.

What is Pantoprazole?

Pantoprazole has active ingredients of pantoprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 285,165 Pantoprazole users. Check the latest studies of Pantoprazole.

What is Evenity?

Evenity has active ingredients of romosozumab-aqqg. eHealthMe is studying from 9,485 Evenity users. Check the latest studies of Evenity.



On Jul, 10, 2026

42 people who take Pantoprazole and Evenity together, and have interactions are studied.

Pantoprazole and Evenity drug interactions.

What are the common drug interactions of Pantoprazole and Evenity, by gender? *:

female:

  1. Carotid arteriosclerosis (plaque deposition in artery)
  2. Carotid artery stenosis (narrowing of carotid artery)
  3. Cerebral infarction (less blood supply to brain resulting tissue damage)
  4. Conjunctivitis bacterial (infection of conjunctiva by bacteria)
  5. Acute myocardial infarction (acute heart attack)
  6. Sinusitis (inflammation of sinus)
  7. Hip fracture
  8. Back pain
  9. Dehydration (dryness resulting from the removal of water)
  10. Ear infection

male:

  1. Drug ineffective
  2. Fall
  3. Shock haemorrhagic (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin due to excess bleeding)
  4. Femur fracture
  5. Injection site discolouration
  6. Injection site pain
  7. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  8. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  9. Depression suicidal (suicide depressive disorder)
  10. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)

What are the common drug interactions of Pantoprazole and Evenity, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Upper airway obstruction
  2. Upper respiratory tract infection
  3. Asthma
  4. Dyspnoea (difficult or laboured respiration)
  5. Dyspnoea exertional (breathlessness or shortness of breath)
  6. Heart rate irregular
  7. Infection
  8. Influenza
  9. Pneumonia
  10. Pyrexia (fever)

50-59:

  1. Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
  2. Pneumonia
  3. Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
  4. Salmonellosis (an infection with salmonella bacteria)

60+:

  1. Acute myocardial infarction (acute heart attack)
  2. Femur fracture
  3. Multiple fractures
  4. Pain
  5. Spinal cord ischaemia (lack of blood supply to spinal cord)
  6. Urinary retention (the inability to completely or partially empty the bladder)
  7. Fall
  8. Angiopathy (generic term for a disease of the blood vessels)
  9. Aortic valve disease
  10. Blood sodium decreased

What are the existing conditions these people have? *

  1. Osteoporosis (bones weak and more likely to break): 15 people, 35.71%
  2. Osteoporosis Post-Menopausal (weak bone with possibility to break after stopped menstrual cycles): 10 people, 23.81%
  3. High Blood Pressure: 6 people, 14.29%
  4. Immunodeficiency Common Variable: 5 people, 11.90%
  5. Pain: 4 people, 9.52%
  6. Insomnia (sleeplessness): 3 people, 7.14%
  7. High Blood Cholesterol: 3 people, 7.14%
  8. Dyspnea (difficult or laboured breathing): 3 people, 7.14%
  9. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 3 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Pantoprazole and Evenity?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Pantoprazole and Evenity:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Pantoprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Evenity:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pantoprazole and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Evenity and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on pantoprazole sodium and romosozumab-aqqg (the active ingredients of Pantoprazole and Evenity, respectively), and Pantoprazole and Evenity (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: